Acadian Asset Management
ORGO icon

Acadian Asset Management’s Organogenesis Holdings ORGO Stock Holding History

Acadian Asset Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.75M Sell
1,545,086
-31,559
-2% -$77.1K ﹤0.01% 887
2026
Q1 		$3.73M Buy
1,576,645
+116,286
+8% +$403K 0.01% 782
2025
Q4 		$7.56M Sell
1,460,359
-292,871
-17% -$1.42M 0.01% 546
2025
Q3 		$7.39M Sell
1,753,230
-671,133
-28% -$3.12M 0.01% 544
2025
Q2 		$8.86M Buy
2,424,363
+91,118
+4% +$340K 0.02% 455
2025
Q1 		$10.1M Sell
2,333,245
-751,458
-24% -$3.03M 0.03% 332
2024
Q4 		$9.87M Buy
3,084,703
+65,655
+2% +$220K 0.03% 363
2024
Q3 		$8.63M Sell
3,019,048
-55,327
-2% -$155K 0.03% 372
2024
Q2 		$8.61M Buy
3,074,375
+72,696
+2% +$195K 0.03% 381
2024
Q1 		$8.52M Buy
3,001,679
+471,741
+19% +$1.6M 0.03% 343
2023
Q4 		$10.3M Sell
2,529,938
-60,306
-2% -$169K 0.04% 283
2023
Q3 		$8.23M Buy
2,590,244
+548,175
+27% +$1.74M 0.03% 324
2023
Q2 		$6.78M Buy
2,042,069
+633,356
+45% +$1.87M 0.03% 377
2023
Q1 		$3M Buy
1,408,713
+219,098
+18% +$541K 0.01% 604
2022
Q4 		$3.2M Buy
1,189,615
+382,817
+47% +$1.12M 0.02% 557
2022
Q3 		$2.61M Buy
+806,798
New +$3.65M 0.01% 556
2022
Q1 		– Sell
-2,600
Closed -$24K – 1751
2021
Q4 		$24K Sell
2,600
-195,276
-99% -$2.07M ﹤0.01% 1588
2021
Q3 		$2.82M Buy
197,876
+65,443
+49% +$1.02M 0.01% 596
2021
Q2 		$2.2M Buy
132,433
+97,891
+283% +$1.82M 0.01% 690
2021
Q1 		$630K Buy
+34,542
New +$468K ﹤0.01% 1115

Other funds holding ORGO

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Acadian Asset Management's ORGO Position: Q2 2026 in Review

Acadian Asset Management reduced its Organogenesis Holdings (ORGO) stake by 2% in Q2 2026, selling an estimated $77.1K and leaving 1,545,086 shares worth $3.75M. The position accounts for ﹤0.01% of the portfolio, ranked #887.

Acadian Asset Management first reported a position in ORGO in Q1 2021 and has held it in 20 quarters since. The position peaked at $10.3M in Q4 2023. 136 funds tracked by Wall St. Rank hold ORGO as of Q2 2026.

  • Acadian Asset Management held 1,545,086 shares of Organogenesis Holdings worth $3.75M as of Q2 2026.
  • Acadian Asset Management sold 31,559 Organogenesis Holdings shares in Q2 2026, an estimated $77.1K.
  • Organogenesis Holdings made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #887 holding.
  • Acadian Asset Management first reported a position in Organogenesis Holdings in Q1 2021 and has held it in 20 quarters since.
  • Acadian Asset Management's Organogenesis Holdings position peaked at $10.3M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.